Form 4: Surgery Partners Director Laura Forese Acquires Over 6,800 Shares

Laura L. Forese, a Director at Surgery Partners, Inc. (SGRY), has acquired 6,861 shares of common stock at a price of $23.32 per share, with the shares set to vest in June 2026.

Summary

• Laura L. Forese, a Director of Surgery Partners, Inc. (SGRY), acquired 6,861 shares of the company's common stock.
• The transaction occurred on June 10, 2025, at a price of $23.32 per share.
• These acquired shares are scheduled to vest on June 10, 2026.
• Following this transaction, Ms. Forese directly beneficially owns 6,861 shares of Surgery Partners common stock.

Sentiment

Score: 7

Explanation: The sentiment is positive as a director's acquisition of shares typically signals confidence in the company's future performance and aligns insider interests with shareholders. This is generally viewed favorably by the market.

Positives

• The acquisition of shares by a company director, Laura L. Forese, indicates a vote of confidence in the company's future prospects and aligns her interests with those of shareholders.
• The purchase price of $23.32 per share suggests a specific valuation point at which the insider deemed the stock attractive.

Future Outlook

The acquired shares are subject to a vesting period, indicating that the full beneficial ownership and liquidity for the director will be realized on June 10, 2026.

Management Comments

• The transaction itself, an acquisition of shares by a director, can be interpreted as a positive signal from management regarding the company's value and future.

Industry Context

Insider transactions, such as the acquisition of shares by a director, are a routine part of corporate governance and compensation in publicly traded companies across all industries. While this specific filing does not provide broader industry trends, insider buying can sometimes signal management's positive outlook on their company's performance relative to its peers in the healthcare services sector.

Related Party Transactions

• The transaction involves a director of Surgery Partners, Inc. acquiring shares of the company, which is a common form of related-party transaction (insider trading) reported under SEC regulations.

Stakeholder Impact

• Shareholders: May view the director's share acquisition as a positive signal, potentially increasing confidence in the company's stock.
• Employees: No direct impact mentioned, but a positive signal from leadership could indirectly boost morale.

Next Steps

• The acquired shares will vest on June 10, 2026, at which point the director will have full, unrestricted ownership of these shares.

Key Dates

Keywords

Surgery Partners, SGRY, Insider Trading, Form 4, Stock Acquisition, Director, Common Stock, Beneficial Ownership